AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2019
Dec 27, 2019
32566_dirs_2019-12-27_af6160ab-4a9d-4c00-9e2e-80bbe983c0cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-12-26
Reporting Person: Ford Alexander (President, MWH)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-26 | Common Stock | M | 1307 | $15.98 | Acquired | 149711 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-26 | Incentive Stock Option (right to buy) | $15.98 | M | 1307 | Disposed | 2020-06-22 | Common Stock (1307) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2